Evolocumab Trial: New Hope for High Cholesterol Patients
Beyond Statins: How Evolocumab Signals a New Era in Proactive Cardiovascular Care Nearly one in ten adults in the United States lives with cardiovascular disease (CVD), costing the nation over $240 billion annually. But what if we could significantly reduce the risk of a first heart attack or stroke, even in individuals who appear relatively … Read more